Rachel Mynott is helping to Improve therapies to treat multiple myeloma

Rachel’s dream is to improve therapies to treat, and ultimately cure, multiple myeloma. She’s working on it… and it’s all thanks to you.
It’s not uncommon for the multiple myeloma research team to be walking though the Flinders Centre for Innovation in Cancer alongside supervisor Dr Craig Wallington-Beddoe and stop to chat with one of his patients.
These encounters, however brief, are a source of enormous motivation for PhD researcher Rachel Mynott. She hopes it is equally as encouraging for patients and their families. “These aren’t faceless patients to us, they’re just downstairs - we see them, we meet them, and we hear about their outcomes,” she says.
“Multiple myeloma is incurable, that’s something we’d obviously like to change.”
Your generous donations to the Autumn newsletter and multiple myeloma tax appeal in 2020 will go towards part-funding Rachel’s three-year PhD scholarship to investigate this aggressive blood cancer of the plasma cells in bone marrow. Thank you for your generous support.
Rachel's focus will be on finding different pathways to target and kill cancer cells, including one which looks at loading the cells with iron to see how they respond. “There’s some really good drugs out there to improve life expectancy for people with multiple myeloma but despite that, people still develop resistance to these treatments,” Rachel says.
“So, we need to find a different way to trick the cells into dying…the end goal is to increase the efficacy of the drugs being used.”
Rachel is grateful for the opportunity to improve life expectancy and give hope to people diagnosed with the disease.
“It’s so nice to know we’re not just here on our own doing research and there are people who care and want to make it better for patients. Thank you.”
Additional funds raised through the tax appeal and a variety of other initiatives will support further research by Dr Craig Wallington- Beddoe – click here for more information about Craig's research.
You can support multiple myeloma research at Flinders Donate Now
More News
Stroke Rehab goes Virtual
Researchers from Flinders University and UniSA are set to develop a new rehabilitation technique for stroke survivors using state-of-the-art Virtual Reality (VR) technology.
Stroke Rehab goes Virtual
Researchers from Flinders University and UniSA are set to develop a new rehabilitation technique for stroke survivors using state-of-the-art Virtual Reality (VR) technology.
New Hope for Pancreatic Cancer
Dr Jean Winter and her Flinders University research team will soon begin trials of a world-first blood biomarker test for patients with pancreatic cancer.
New Hope for Pancreatic Cancer
Dr Jean Winter and her Flinders University research team will soon begin trials of a world-first blood biomarker test for patients with pancreatic cancer.
Help for families in gambling battle
The Southern Adelaide Local Health Network’s (SALHN) Statewide Gambling Therapy Service provides psychological therapies to individuals with gambling addictions.
Help for families in gambling battle
The Southern Adelaide Local Health Network’s (SALHN) Statewide Gambling Therapy Service provides psychological therapies to individuals with gambling addictions.
Rapid access to surgical procedures
Podiatrists at Noarlunga Hospital will trial a new model of care for anxious patients, to help them get rapid access to some minor surgical procedures.
Rapid access to surgical procedures
Podiatrists at Noarlunga Hospital will trial a new model of care for anxious patients, to help them get rapid access to some minor surgical procedures.
$1 Million in grants awarded
$1 million in grants awarded to 23 health and medical research projects across Southern Adelaide
$1 Million in grants awarded
$1 million in grants awarded to 23 health and medical research projects across Southern Adelaide
31 New Health and Medical Research Projects
Health and medical researchers across the Flinders Medical Precinct will share in $750,000 funding, to support exciting research projects across a variety of illnesses, diseases, and social issues.
31 New Health and Medical Research Projects
Health and medical researchers across the Flinders Medical Precinct will share in $750,000 funding, to support exciting research projects across a variety of illnesses, diseases, and social issues.
Grateful Tony Gives Back
Struggling to get a breath in and feeling like he was “choking to death”, Tony de Maaijer knew he was in a bad way.
Grateful Tony Gives Back
Struggling to get a breath in and feeling like he was “choking to death”, Tony de Maaijer knew he was in a bad way.
New Funding for Cancer Research
World Cancer Day (February 4) marked the announcement of funding for four new cancer research projects thanks to the generosity of guests and supporters of Flinders Foundation’s Pink Yellow Blue Enchanted Garden event.
New Funding for Cancer Research
World Cancer Day (February 4) marked the announcement of funding for four new cancer research projects thanks to the generosity of guests and supporters of Flinders Foundation’s Pink Yellow Blue Enchanted Garden event.
Tour de Cure’s New Mission to Tackle Head and Neck Cancers
Pedal power is helping to re-shape the monitoring of head and neck cancers in a bid to improve care for patients, particularly those in rural and regional areas.
Tour de Cure’s New Mission to Tackle Head and Neck Cancers
Pedal power is helping to re-shape the monitoring of head and neck cancers in a bid to improve care for patients, particularly those in rural and regional areas.
Ralph’s Legacy The Ralph Ernst Fellowship: Changing the Face of Survival in Prostate and Bladder Cancers
A generous man’s chance encounter with Flinders Medical Centre 35 years ago is now helping to change the future for men with prostate and bladder cancers.
Ralph’s Legacy The Ralph Ernst Fellowship: Changing the Face of Survival in Prostate and Bladder Cancers
A generous man’s chance encounter with Flinders Medical Centre 35 years ago is now helping to change the future for men with prostate and bladder cancers.